Brain tumors are tumors and brain metastases that originate in intracranial tissue, manifested as increased intracranial pressure and various neurological symptoms. More than half of brain tumors are malignant tumors.
Features of Precise Diagnosis and Treatment for Brain Cancer
This test comprehensively detects the molecular signatures of relevant tumor drugs approved by NMPA/FDA, as well as the genes related to typing, diagnosis, prognosis and medication in NCCN/CSCO/WHO guidelines, brain tumor research and related clinical trials. Provide accurate and comprehensive evaluation for molecular typing, auxiliary diagnosis, prognosis and drug treatment of brain tumor patients.
This panel is customized by authoritative institutions - Department of Neurosurgery, Beijing Tiantan Hospital, including 4 mutant types - 52 SNVs and Indels, 25 CNVs, 8 gene fusions, and 6 co-deletions/amplifications at the chromosome level.
Applicable Population of Precise Diagnosis and Treatment for Brain Cancer
Newly diagnosed / recurrent brain tumor patients
Specification of Precise Diagnosis and Treatment for Brain Cancer